Research Highlights: CD24, a promising biomarker in NSCLC

Biomarkers in Medicine

Volumn 4, Issue 4, 2010, Pages 495-

  Rosser, Charles J ^a   Goodison, Steve ^a  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD24 ANTIBODY; CD24 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CD24 GENE; CELL ADHESION; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MOLECULAR BIOLOGY; SHORT SURVEY; SURVIVAL TIME; UNITED STATES;

EID: 77955593074     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.10.77     Document Type: Short Survey

References (2)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J. Clin. 59(4), 225-249 (2009)
2. Kristiansen G, Sammar M, Altevogt P: Tumour biological aspects of CD24, a mucin-like adhesion molecule. J. Mol. Histol. 35(3), 255-262 (2004